<DOC>
	<DOCNO>NCT02828319</DOCNO>
	<brief_summary>To confirm safety efficacy Z-213 12 week start Z-213 administration patient iron deficiency Anemia</brief_summary>
	<brief_title>Clinical Study Z-213 Subjects With Iron-deficiency Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<criteria>Patients iron deficiency anemia Patients anemia cause condition iron deficiency Patients abnormal laboratory test value screen Serum phosphorus , Aspartate aminotransferase , Alanine aminotransferase Patients liver , kidney circulatory system disease Patients history present illness malignant tumor autoimmune disease Patients underwent intravenous administration iron preparation , administration erythropoiesis stimulation agent blood transfusion within 8 week screen Patients underwent oral administration iron preparation ( include overthecounter drug supplement ) within 4 week screen</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>